Centene Corporation
CNC
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Centene Corporation působí jako nadnárodní zdravotnický podnik, který poskytuje programy a služby nedostatečně pojištěným a nepojištěným osobám ve Spojených státech. Jeho segment Managed Care nabízí krytí zdravotních plánů jednotlivcům prostřednictvím vládou dotovaných programů, včetně programu Medicaid, státního programu zdravotního pojištění dětí, dlouhodobých služeb a podpory, pěstounské péče a plánů medicare-medicaid, které zahrnují osoby s dvojí kvalifikací, stejně jako programy pro starší, nevidomé nebo postižené. Její zdravotnické plány zahrnují primární a specializovanou lékařskou péči, nemocniční péči v lůžkových a ambulantních zařízeních, urgentní a urgentní péči, prenatální péči, laboratorní a rentgenovou péči, domácí primární péči, dopravní pomoc, zrakovou péči, zubní péči, telezdravotnictví, imunizaci, specializovanou lékárnu, terapii, sociální práci, poradenství pro zdravotní sestry a koordinační služby v oblasti péče, jakož i předpisy a omezené volně prodejné léky, zdravotnické vybavení a behaviorální zdravotnické a zneužívací služby. Tento segment také nabízí různé individuální, malé skupiny a velké skupiny komerčních zdravotnických produktů zaměstnavatelům a přímo členům. Segment specializovaných služeb společnosti poskytuje služby řízení lékárenských dávek, poradenství zdravotních sester a podpůrné služby po pracovní době, vizuální a zubařské služby, jakož i personální služby nápravným systémům a dalším vládním agenturám a služby oprávněným příjemcům z Vojenského zdravotnického systému. Tento segment nabízí své služby a produkty státním programům, nápravným zařízením, zdravotnickým organizacím, skupinám zaměstnavatelů a dalším komerčním organizacím. Společnost poskytuje své služby prostřednictvím primární a specializované péče lékařů, nemocnic a pomocných poskytovatelů. Centene Corporation byla založena v roce 1984 a sídlí v St. Louis v Missouri.
Sektor
Healthcare
Odvětví
Medical - Healthcare Plans
Počet zaměstnanců
60400
Založení
2001-12-13
Podobné společnosti
$ 196.49
- $ 8.78
$ 590.04
+ $ 0.89
$ 74.19
+ $ 0.09
$ 33.36
+ $ 0.13
$ 220.64
- $ 8.59
$ 23.80
- $ 0.20
$ 121.82
- $ 0.08
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 194.8 | 194.8 | 163.1 | 154.0 | 144.5 | 126.0 | 111.1 | 74.6 | 60.1 | 48.4 | 40.6 | 22.8 | 16.6 | 10.9 | 8.7 | 5.3 | 4.4 | |
| Cost of Revenues | 170.9 | 170.9 | 146.2 | 122.5 | 127.9 | 111.8 | 95.9 | 65.8 | 51.7 | 42.6 | 35.1 | 20.0 | 14.7 | 9.7 | 8.0 | 4.4 | 3.7 | |
| Gross Profit | 23.8 | 23.8 | 16.8 | 31.5 | 16.7 | 14.2 | 15.2 | 8.8 | 8.4 | 5.8 | 5.5 | 2.7 | 1.9 | 1.2 | 0.7 | 0.9 | 0.7 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 49.7 | 49.7 | 48.7 | 46.6 | 40.8 | 42.0 | 39.8 | 40.4 | 39.5 | 38.0 | |
| Cost of Revenues | 42.2 | 41.6 | 45.8 | 41.4 | 37.1 | 38.0 | 35.4 | 35.8 | 31.6 | 30.3 | |
| Gross Profit | 7.5 | 8.1 | 2.9 | 5.2 | 3.7 | 4.0 | 4.4 | 4.6 | 7.9 | 7.7 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 12.6 | 11.6 | 10.2 | 11.3 | 6.5 | 6.8 | 4.4 | 4.1 | 2.0 | 1.4 | 0.9 | 0.7 | 0.6 | 0.5 | |
| Depreciation & Amortization | 1.3 | 1.3 | 1.2 | 1.3 | 1.6 | 1.5 | 1.3 | 0.9 | 0.5 | 0.4 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Total Operating Expenses | 31.5 | 31.5 | 13.7 | 28.6 | 13.0 | 10.9 | 12.1 | 6.8 | 7.0 | 4.6 | 4.3 | 2.0 | 1.4 | 0.9 | 0.7 | 0.7 | 0.5 | |
| Operating Income | -7.6 | -7.6 | 3.2 | 2.9 | 3.6 | 3.3 | 3.1 | 1.8 | 1.5 | 1.2 | 1.3 | 0.7 | 0.5 | 0.3 | 0.0 | 0.2 | 0.2 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.5 | 3.0 | ||
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | ||
| Total Operating Expenses | 9.3 | 15.1 | 3.4 | 3.7 | 3.5 | 3.4 | 3.2 | 3.5 | 8.1 | 7.0 | ||
| Operating Income | -1.7 | -7.0 | -0.5 | 1.5 | 0.2 | 0.7 | 1.2 | 1.1 | -0.2 | 0.7 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.4 | 0.3 | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 0.9 | 0.9 | 1.1 | 0.7 | -1.7 | -1.5 | -0.3 | 0.0 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| IBT | -6.7 | -6.7 | 4.3 | 3.6 | 2.0 | 1.8 | 2.8 | 1.8 | 1.4 | 1.1 | 1.2 | 0.7 | 0.5 | 0.3 | 0.0 | 0.2 | 0.2 | |
| Income Tax Expense | -0.1 | -0.1 | 1.0 | 0.9 | 0.8 | 0.5 | 1.0 | 0.5 | 0.5 | 0.3 | 0.6 | 0.3 | 0.2 | 0.1 | 0.0 | 0.1 | 0.1 | |
| Net Income | -6.7 | -6.7 | 3.3 | 2.7 | 1.2 | 1.3 | 1.8 | 1.3 | 0.9 | 0.8 | 0.6 | 0.4 | 0.3 | 0.2 | 0.0 | 0.1 | 0.1 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | ||
| Interest Expense | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | ||
| Other Expense | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 | 0.2 | 0.0 | ||
| IBT | -1.5 | -6.7 | -0.3 | 1.7 | 0.3 | 0.9 | 1.5 | 1.5 | 0.0 | 0.8 | ||
| Income Tax Expense | -0.4 | 0.0 | 0.0 | 0.4 | 0.1 | 0.2 | 0.4 | 0.3 | 0.0 | 0.3 | ||
| Net Income | -1.1 | -6.6 | -0.3 | 1.3 | 0.3 | 0.7 | 1.1 | 1.2 | 0.0 | 0.5 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $4.97 | $2.09 | $2.31 | $3.17 | $3.19 | $2.31 | $2.40 | $1.76 | $1.49 | $1.17 | $0.76 | $0.01 | $0.56 | $0.49 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $4.95 | $2.07 | $2.28 | $3.12 | $3.14 | $2.26 | $2.35 | $1.72 | $1.44 | $1.13 | $0.74 | $0.01 | $0.53 | $0.47 | |
| Shares Outstanding | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.4 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| Diluted Shares Outstanding | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.4 | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.87 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.87 | ||
| Shares Outstanding | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | ||
| Diluted Shares Outstanding | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 17.6 | 14.1 | 17.2 | 12.1 | 13.1 | 10.8 | 12.1 | 5.3 | 4.1 | 3.9 | 1.8 | 1.6 | 1.0 | 0.8 | 0.6 | 0.4 | |
| Short Term Investments | 2.6 | 2.6 | 2.5 | 2.3 | 1.5 | 1.6 | 0.9 | 0.7 | 0.5 | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Total Cash & ST Investments | 20.2 | 16.7 | 19.7 | 14.4 | 14.7 | 12.4 | 13.0 | 6.1 | 4.6 | 4.4 | 1.9 | 1.8 | 1.1 | 1.0 | 0.7 | 0.5 | |
| Accounts Receivable | 16.6 | 19.7 | 0.0 | 13.3 | 12.2 | 9.7 | 6.2 | 5.2 | 3.4 | 3.1 | 1.3 | 0.9 | 0.4 | 0.3 | 0.2 | 0.1 | |
| Inventory | -36.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 38.4 | 1.6 | 21.1 | 2.5 | 1.6 | 1.3 | 1.1 | 0.8 | 0.7 | 0.8 | 0.4 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Total Current Assets | 38.4 | 38.0 | 40.8 | 30.1 | 28.5 | 23.4 | 20.3 | 12.0 | 8.7 | 8.4 | 3.6 | 3.0 | 1.8 | 1.4 | 0.9 | 0.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 17.1 | 14.5 | 14.8 | 14.1 | 14.6 | 17.6 | 17.6 | 17.2 | 18.2 | 17.2 | |
| Short Term Investments | 2.2 | 2.8 | 2.5 | 2.6 | 3.0 | 2.6 | 2.1 | 2.5 | 2.2 | 2.2 | |
| Total Cash & ST Investments | 19.2 | 17.3 | 17.3 | 16.7 | 17.6 | 20.2 | 19.7 | 19.7 | 20.4 | 19.4 | |
| Accounts Receivable | 23.1 | 21.6 | 22.4 | 19.7 | 18.3 | 16.6 | 16.8 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -35.2 | 0.0 | 0.0 | |
| Other Current Assets | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 2.0 | 21.1 | 21.0 | 15.5 | |
| Total Current Assets | 44.1 | 40.4 | 41.3 | 38.0 | 37.4 | 38.4 | 38.4 | 40.8 | 41.4 | 34.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 2.0 | 2.4 | 2.4 | 2.4 | 3.4 | 2.8 | 2.1 | 1.7 | 1.1 | 0.8 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | |
| Goodwill | 17.6 | 17.6 | 17.6 | 18.8 | 19.8 | 18.7 | 6.9 | 7.0 | 4.7 | 4.7 | 0.8 | 0.8 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Intangible Assets | 5.8 | 5.4 | 6.1 | 6.9 | 7.8 | 8.4 | 2.1 | 2.2 | 1.4 | 1.5 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 16.9 | 17.4 | 16.3 | 14.7 | 14.0 | 12.9 | 7.7 | 6.9 | 5.3 | 4.5 | 1.9 | 1.3 | 0.8 | 0.6 | 0.5 | 0.6 | |
| Other Long-Term Assets | 2.7 | 1.6 | 1.5 | 3.9 | 4.8 | 2.7 | 1.9 | 1.1 | 0.6 | 0.2 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Total Long-Term Assets | 44.7 | 44.4 | 43.9 | 46.7 | 49.9 | 45.3 | 20.7 | 18.9 | 13.2 | 11.8 | 3.7 | 2.8 | 1.7 | 1.4 | 1.3 | 1.3 | |
| Total Assets | 83.1 | 82.4 | 84.6 | 76.9 | 78.4 | 68.7 | 41.0 | 30.9 | 21.9 | 20.2 | 7.3 | 5.8 | 3.5 | 2.7 | 2.2 | 1.9 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 2.2 | 2.1 | 2.0 | 2.4 | 2.0 | 2.0 | 2.0 | 2.0 | 2.4 | 2.4 | |
| Goodwill | 10.8 | 17.6 | 17.6 | 17.6 | 17.6 | 17.6 | 17.6 | 17.6 | 17.6 | 18.7 | |
| Intangible Assets | 4.8 | 5.0 | 5.2 | 5.4 | 5.6 | 5.8 | 5.9 | 6.1 | 6.3 | 6.5 | |
| Long-Term Investments | 18.2 | 18.8 | 18.3 | 17.4 | 17.7 | 16.9 | 16.5 | 16.3 | 15.2 | 16.1 | |
| Other Long-Term Assets | 2.0 | 2.5 | 2.7 | 1.6 | 2.1 | 2.5 | 2.2 | 6.1 | 1.5 | 4.2 | |
| Total Long-Term Assets | 38.0 | 46.0 | 45.8 | 44.4 | 44.9 | 44.7 | 44.2 | 43.9 | 43.0 | 48.0 | |
| Total Assets | 82.1 | 86.4 | 87.0 | 82.4 | 82.4 | 83.1 | 82.6 | 84.6 | 84.4 | 82.9 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 13.8 | 13.0 | 16.3 | 9.5 | 8.5 | 7.1 | 4.2 | 4.1 | 4.2 | 3.8 | 1.0 | 0.8 | 0.4 | 0.2 | 0.2 | 0.2 | |
| Short-Term Debt | 0.1 | 0.3 | 0.3 | 0.1 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 18.2 | 20.3 | 19.3 | 18.4 | 16.6 | 13.9 | 8.3 | 7.5 | 4.8 | 4.5 | 2.5 | 2.0 | 1.1 | 1.0 | 0.6 | 0.5 | |
| Current Liabilities | 32.7 | 34.3 | 36.7 | 28.5 | 25.8 | 21.6 | 12.9 | 12.0 | 9.3 | 8.6 | 3.6 | 2.9 | 1.6 | 1.2 | 0.8 | 0.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 16.9 | 13.5 | 13.9 | 13.0 | 13.3 | 12.2 | 12.1 | 16.3 | 14.9 | 9.7 | |
| Short-Term Debt | 0.0 | 0.0 | 0.0 | 0.3 | 0.1 | 0.1 | 0.1 | 0.3 | 0.5 | 0.3 | |
| Other Current Liabilities | 23.1 | 22.6 | 22.3 | 20.3 | 20.0 | 19.8 | 19.9 | 1.6 | 1.7 | 7.0 | |
| Current Liabilities | 40.6 | 36.8 | 37.1 | 34.3 | 34.1 | 32.7 | 32.8 | 36.7 | 36.9 | 31.3 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 17.5 | 19.2 | 18.6 | 17.9 | 18.6 | 16.7 | 13.6 | 6.6 | 4.7 | 4.7 | 1.2 | 0.9 | 0.7 | 0.5 | 0.3 | 0.3 | |
| Capital Leases | 0.0 | 0.9 | 1.0 | 3.3 | 0.0 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.7 | 0.7 | 0.6 | 0.6 | 1.4 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 55.7 | 55.9 | 58.7 | 52.6 | 51.4 | 42.8 | 28.3 | 19.9 | 15.0 | 14.1 | 5.0 | 3.9 | 2.3 | 1.8 | 1.3 | 1.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 17.5 | 17.6 | 18.3 | 19.2 | 17.5 | 17.5 | 17.9 | 17.7 | 18.8 | 17.9 | |
| Capital Leases | 0.0 | 0.0 | 0.0 | 0.9 | 0.0 | 0.0 | 0.0 | 1.0 | 1.1 | 3.3 | |
| Def. Tax Liability | 0.8 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | |
| Total Liabilities | 61.0 | 58.9 | 59.0 | 55.9 | 54.9 | 55.7 | 55.6 | 58.7 | 59.0 | 57.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 14.4 | 15.3 | 12.0 | 9.3 | 8.1 | 6.8 | 5.0 | 3.7 | 2.7 | 1.9 | 1.4 | 1.0 | 0.7 | 0.6 | 0.6 | 0.5 | |
| Comprehensive Income | -0.6 | -0.5 | -0.7 | -1.1 | 0.1 | 0.3 | 0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 27.4 | 26.4 | 25.8 | 24.1 | 26.8 | 25.8 | 12.6 | 10.9 | 6.9 | 5.9 | 2.2 | 1.7 | 1.2 | 1.0 | 0.9 | 0.8 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 9.8 | 16.4 | 16.7 | 15.3 | 15.1 | 14.4 | 13.2 | 12.0 | 12.0 | 11.5 | |
| Comprehensive Income | -0.1 | -0.2 | -0.3 | -0.5 | -0.2 | -0.6 | -0.6 | -0.7 | -1.1 | -1.0 | |
| Total Common Equity | 20.9 | 27.4 | 27.9 | 26.4 | 27.3 | 27.4 | 27.0 | 25.8 | 25.3 | 25.7 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 17.6 | 19.4 | 18.9 | 18.0 | 18.8 | 16.8 | 13.7 | 6.7 | 4.7 | 4.7 | 1.2 | 0.9 | 0.7 | 0.5 | 0.4 | 0.3 | |
| Book Value | 27.5 | 26.5 | 26.0 | 24.2 | 27.0 | 26.0 | 12.7 | 11.0 | 6.9 | 6.1 | 2.3 | 1.9 | 1.2 | 1.0 | 0.9 | 0.8 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Book Value | 20.9 | 27.4 | 27.9 | 26.4 | 27.3 | 27.4 | 27.0 | 25.8 | 25.3 | 25.7 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.8 | -6.7 | 3.3 | 2.7 | 1.2 | 1.3 | 1.8 | 1.3 | 0.9 | 0.8 | 0.6 | 0.4 | 0.3 | 0.2 | 0.0 | 0.1 | 0.1 | |
| Depreciation & Amortization | 1.3 | 1.3 | 1.2 | 1.3 | 1.6 | 1.5 | 1.3 | 0.6 | 0.5 | 0.4 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Stock-Based Compensation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change Working Capital | -2.0 | 0.8 | -4.5 | 3.4 | 2.2 | 1.4 | 2.2 | -1.0 | -0.2 | 0.3 | 0.8 | 0.1 | 0.9 | 0.1 | 0.2 | 0.1 | 0.0 | |
| Change In Accounts Receivable | -3.1 | 1.5 | -4.3 | -2.4 | -1.6 | -2.5 | -0.1 | -1.1 | -1.2 | -0.1 | 0.1 | -0.4 | -0.5 | -0.1 | -0.1 | 0.0 | 0.0 | |
| Change In Accounts Payable | 0.4 | -0.7 | -0.5 | 3.4 | 0.4 | 1.1 | 0.6 | -0.4 | -0.5 | 0.1 | 0.4 | 0.0 | 0.5 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 2.1 | 0.0 | -1.1 | -0.6 | 0.4 | 1.5 | 0.3 | 0.3 | 0.5 | 0.6 | 0.1 | 0.3 | 0.0 | 0.0 | |
| Other Non-cash Items | 1.9 | 9.5 | -0.1 | 0.5 | 1.7 | -0.1 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Operations | 3.0 | 0.0 | 0.0 | 8.1 | 6.3 | 4.2 | 5.5 | 1.5 | 1.2 | 1.5 | 1.9 | 0.7 | 1.2 | 0.4 | 0.3 | 0.3 | 0.2 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1.1 | -6.6 | -0.3 | 1.3 | 0.3 | 0.7 | 1.1 | 1.2 | 0.0 | 0.5 | |
| Depreciation & Amortization | 0.0 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Stock-Based Compensation | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | |
| Change Working Capital | 0.7 | -1.6 | 1.7 | -0.2 | -1.2 | -2.0 | 0.7 | -2.0 | -0.2 | -0.5 | |
| Change In Accounts Receivable | 0.0 | -1.5 | 0.9 | -2.7 | -1.6 | -1.7 | 0.2 | -1.2 | -0.1 | -2.0 | |
| Change In Accounts Payable | 0.0 | 2.1 | 0.0 | 0.6 | 0.0 | 0.9 | 0.0 | 0.0 | 1.9 | 0.0 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 0.8 | 9.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.1 | 0.5 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 1.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.7 | -0.8 | -0.6 | -0.8 | -1.0 | -0.9 | -0.9 | -0.7 | -0.7 | -0.4 | -0.3 | -0.2 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | |
| Acquisitions | 1.0 | 0.0 | 1.0 | 0.7 | 1.0 | -0.5 | -3.6 | 0.0 | -2.1 | -0.1 | -1.3 | 0.0 | -0.1 | -0.1 | 0.1 | 0.0 | -0.1 | |
| Investments | -6.9 | -4.5 | -7.2 | -6.6 | -6.7 | -7.4 | -7.4 | -2.6 | -3.8 | -2.7 | -2.5 | -1.3 | -1.0 | -0.8 | -0.7 | -0.3 | -0.6 | |
| Sales of Investment | 5.7 | 5.8 | 5.8 | 5.5 | 3.8 | 5.5 | 4.9 | 1.8 | 2.0 | 1.9 | 1.7 | 0.7 | 0.4 | 0.6 | 0.6 | 0.3 | 0.6 | |
| Other Investing Activities | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | |
| Cash from Investing | -0.8 | 0.0 | 0.0 | -1.2 | -2.9 | -3.3 | -7.0 | -1.5 | -4.6 | -1.3 | -2.4 | -0.8 | -0.8 | -0.3 | -0.2 | -0.1 | -0.2 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.2 | -0.2 | -0.2 | -0.1 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.9 | 0.0 | 0.0 | |
| Investments | -0.8 | -0.2 | -2.0 | -1.6 | -1.4 | -2.3 | -2.1 | -1.3 | -1.9 | -1.5 | |
| Sales of Investment | 1.6 | 1.6 | 1.3 | 1.2 | 1.6 | 1.7 | 1.1 | 1.4 | 1.2 | 2.1 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.7 | 0.6 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | 0.4 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -1.4 | 0.0 | 0.0 | 0.0 | -1.5 | -7.6 | -4.1 | -17.8 | -4.1 | -1.4 | -6.1 | -1.6 | -1.7 | 0.0 | -0.2 | -0.4 | -0.2 | |
| Debt Issued | 1.0 | 19.4 | 0.6 | 0.9 | 0.7 | 9.7 | 7.2 | 24.9 | 6.1 | 1.4 | 9.5 | 1.9 | 1.9 | 0.2 | 0.4 | 0.4 | 0.5 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 2.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Repurchase of Common Stock | -1.8 | -0.5 | -3.1 | -1.6 | -3.1 | -0.3 | -0.6 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 1.8 | 0.0 | 0.0 | 0.0 | 0.3 | 9.3 | 5.0 | 24.7 | 12.1 | 1.3 | 8.9 | 1.9 | 1.9 | 0.4 | 0.4 | 0.4 | 0.2 | |
| Cash from Financing | -1.9 | 0.0 | 0.0 | -1.7 | -4.2 | 1.4 | 0.3 | 6.8 | 4.6 | -0.1 | 2.7 | 0.3 | 0.2 | 0.2 | 0.2 | 0.0 | 0.1 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.2 | |
| Debt Issued | 17.6 | 0.0 | -0.7 | -1.1 | 1.8 | 0.0 | -0.4 | 0.2 | -1.1 | 1.3 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | -0.4 | 0.0 | -0.9 | -1.2 | -0.8 | -0.2 | 0.0 | -0.8 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.5 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.3 | 3.8 | -3.1 | 5.1 | -0.9 | 2.3 | -1.2 | 6.8 | 1.3 | 0.1 | 2.2 | 0.2 | 0.6 | 0.2 | 0.3 | 0.1 | 0.0 | |
| Closing Cash Balance | 17.6 | 18.0 | 14.1 | 17.5 | 12.3 | 13.2 | 11.0 | 12.1 | 5.4 | 4.1 | 3.9 | 1.8 | 1.6 | 1.0 | 0.8 | 0.6 | 0.4 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.8 | 2.5 | -0.3 | 0.8 | -0.5 | -3.0 | 0.0 | 0.4 | -1.0 | 0.9 | |
| Closing Cash Balance | 17.9 | 17.1 | 14.5 | 14.8 | 14.1 | 14.6 | 17.6 | 17.6 | 17.2 | 18.5 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 2.3 | 4.3 | -0.5 | 7.3 | 5.3 | 3.3 | 4.6 | 0.8 | 0.6 | 1.1 | 1.5 | 0.5 | 1.1 | 0.3 | 0.2 | 0.2 | 0.1 | |
| Real Free Cash Flow | 2.0 | 4.1 | -0.7 | 7.0 | 5.0 | 3.1 | 4.4 | 0.6 | 0.4 | 0.9 | 1.4 | 0.4 | 1.1 | 0.3 | 0.2 | 0.2 | 0.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.2 | 1.1 | 1.6 | 1.4 | -0.7 | -1.1 | 2.0 | -0.6 | 0.0 | 0.9 | |
| Real Free Cash Flow | 0.2 | 1.1 | 1.5 | 1.3 | -0.8 | -1.2 | 1.9 | -0.7 | -0.1 | 0.8 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -2.5 | 87.3 | 51.6 |
| P/S | 0.1 | 0.3 | 0.9 |
| P/B | 0.8 | 2.1 | 21.2 |
| P/FCF | 4 | 41 | 152.6 |
| Market cap | $16.8 | $121.6 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 21.2 % | 0 % |
| Debt to Income | -263.5 % | 2194.4 % | 0 % |
| Debt to Free cash flow | 421.1 % | 28.1 % | 0 % |
| Interest expense percentage | -8.9 % | 16.5 % | 0 % |
| Current ratio | 1.1 | 1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -31.9 % | 8.6 % | 0 % |
| ROA | -8.1 % | 2.9 % | 0 % |
| CapEx to Revenue | 0.4 % | 0.9 % | 0 % |
| RaD to Revenue | 0 % | 0 % | 0 % |
| ROEM | 3,219,454.5 | 804383.1 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 12.2 % | 13.5 % | 0 % |
| Operating margin | -3.9 % | 2.2 % | 0 % |
| Net margin | -3.4 % | 1.4 % | 0 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 3.8 % | 0 % |
| Dividend payout percentage | 0 % | 72.9 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 491.1 mil | 383.7 mil |
| Employee count | 60.5 tis | 24.6 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
